Using Nonexperts for Annotating Pharmacokinetic Drug-Drug Interaction Mentions in Product Labeling: A Feasibility Study-Reference-Cited by-同舟云学术

Using Nonexperts for Annotating Pharmacokinetic Drug-Drug Interaction Mentions in Product Labeling: A Feasibility Study

Published:2016-04-11 Issue:2 Volume:5 Page:e40
ISSN:1929-0748
Container-title:JMIR Research Protocols
language:en
Short-container-title:JMIR Res Protoc

Author:

Hochheiser Harry^ORCID,Ning Yifan^ORCID,Hernandez Andres^ORCID,Horn John R^ORCID,Jacobson Rebecca^ORCID,Boyce Richard D^ORCID

Publisher

JMIR Publications Inc.

Subject

General Medicine

Reference41 articles.

1. Epidemiology and characteristics of adverse drug reactions caused by drug–drug interactions

2. Are results from pharmaceutical-company-sponsored studies available to the public?

3. Code of Federal Regulations Title 212015-06-10Washington DCUS Food and Drug Administrationhttp://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=201.57

4. Guidance for industry: indexing structured product labeling2015-11-25Washington DCUS Food and Drug Admininstrationhttp://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm072317.pdf

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of Natural Language Processing in Pharmacology;Pharmacological Reviews;2023-03-17

2. Manual semantic annotations: User evaluation of interface and interaction designs;Journal of Web Semantics;2019-10

3. Reconciliation of patient/doctor vocabulary in a structured resource;Health Informatics Journal;2018-01-13

4. Drug Disposition Considerations in Pharmaceutical Product;Dosage Form Design Considerations;2018

5. An Innovative, Collaborative, and Strategic Approach to Proactively Evaluate and Update Drug Interactions Based on Prescribing Information of Newly Approved Medicinal Products;Therapeutic Innovation & Regulatory Science;2017-11